NCT03513952 2024-07-26Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial CarcinomaNational Cancer Institute (NCI)Phase 2 Completed47 enrolled 14 charts